Yayınlar & Eserler

Yayın Ağı
Makaleler 20
Tümü (20)
SCI-E, SSCI, AHCI (20)
SCI-E, SSCI, AHCI, ESCI (20)
Scopus (20)
TRDizin (3)

1. The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing

KÖSTEK O., Demirel A., Hacıoğlu M. B., TAŞTEKİN D., KARABULUT S., Gündogdu A., et al.
Journal of Chemotherapy , cilt.36, sa.7, ss.613-621, 2024 (SCI-Expanded, Scopus) identifier identifier

2. The impact of radiotherapy on quality of life for cancer patients: a longitudinal study

YÜCEL B., ATASEVER AKKAŞ E., OKUR Y., AY EREN A., EREN M. F., KARAPINAR H., et al.
SUPPORTIVE CARE IN CANCER , cilt.22, sa.9, ss.2479-2487, 2014 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

3. Oxaliplatin and ototoxicity: is it really safe for hearing?

YÜCE S., ŞEKER M. M., KOÇ S., UYSAL İ. Ö., KAÇAN T., DOĞAN M., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.44, sa.4, ss.586-589, 2014 (SCI-Expanded, Scopus, TRDizin) identifier identifier

4. Could the Neutrophil to Lymphocyte Ratio be a Poor Prognostic Factor for Non Small Cell Lung Cancers?

KAÇAN T., AKGÜL BABACAN N., Seker M., Yucel B., BAHÇECİ A., Eren A. A., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, sa.5, ss.2089-2094, 2014 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

5. Clinical Features and Prognostic Factors of Hodgkin's Lymphoma: A Single Center Experience

KILIÇKAP S., BARIŞTA İ., Ulger S., ÇELİK İ., Selek U., YILDIZ F., et al.
BALKAN MEDICAL JOURNAL , cilt.30, sa.2, ss.178-185, 2013 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

6. Smoking Habits of Relatives of Patients with Cancer: Cancer Diagnosis in the Family is an Important Teachable Moment for Smoking Cessation

Hayran M., KILIÇKAP S., Elkiran T., AKBULUT H., Abali H., YÜCE D., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.14, sa.1, ss.475-479, 2013 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

7. Effect of Endocrine Therapy on Quality of Life and Cognitive Functions in Patients with Breast Cancer

KILIÇKAP S., Hayran M., ÇAKIR B., ÇİLİNGİROĞLU N., ERMAN M., Buyukdamgaci G., et al.
BREAST CARE , cilt.8, sa.2, ss.128-132, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

8. Clinical characteristics, treatment and survival outcomes in malignant mesothelioma

BERK S., DOĞAN Ö. T., KILIÇKAP S., EPÖZTÜRK K., AKKURT İ., SEYFİKLİ Z.
EUROPEAN RESPIRATORY JOURNAL , cilt.40, 2012 (SCI-Expanded) identifier

9. Prognosis of Colorectal Cancer With Peritoneal Carcinomatosis: Is a New Staging Necessary?

Kesikli S. A., EREN M. F., AKGÜL BABACAN N., KILIÇKAP S.
JOURNAL OF CLINICAL ONCOLOGY , cilt.30, sa.18, ss.2287-2288, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

10. A new perspective to determine the severity of cases with Crimean-Congo hemorrhagic fever

BAKIR M., ENGİN A., GÖZEL M. G., ELALDI N., KILIÇKAP S., ÇINAR Z.
JOURNAL OF VECTOR BORNE DISEASES , cilt.49, sa.2, ss.105-110, 2012 (SCI-Expanded) identifier identifier identifier

11. Insulin Therapy and Cancer-Specific Mortality in Patients With Colorectal Cancer and Diabetes

Kesikli S. A., Unluturk U., KILIÇKAP S.
JOURNAL OF CLINICAL ONCOLOGY , cilt.30, sa.14, ss.1729-1730, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

12. Complete remission after bevacizumab plus temozolomide in a patient with recurrent glioblastoma multiforme

KILIÇKAP S., ÖZTOPRAK İ., YÜCEL B.
ACTA ONCOLOGICA , cilt.51, sa.4, ss.544-546, 2012 (SCI-Expanded) identifier identifier identifier

13. Cytoreductive Surgery Followed by Hyperthermic Intraperitoneal Chemotherapy: Morbidity and Mortality Analysis of Our Patients

KARADAYI K., TURAN M., KARADAYI Ş., ALAGÖZLÜ H., KILIÇKAP S., Buyukcelik A., et al.
TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , cilt.32, sa.1, ss.162-170, 2012 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

14. Paclitaxel, Not Bevacizumab, Was Primarily Responsible for the Favorable Effects Seen in the RIBBON-2 Trial

Kesikli A., KILIÇKAP S.
JOURNAL OF CLINICAL ONCOLOGY , cilt.30, sa.4, ss.461, 2012 (SCI-Expanded) identifier identifier identifier

15. Screening Colonoscopy Participation in Turkish Colorectal Cancer Patients and their First Degree Relatives

KILIÇKAP S., Arslan C., Rama D., YALÇIN Ş.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.13, sa.6, ss.2829-2832, 2012 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

16. Clinical Characteristics, Treatment and Survival Outcomes in Malignant Mesothelioma: Eighteen Years' Experience in Turkey

BERK S., DOĞAN Ö. T., KILIÇKAP S., EPÖZTÜRK K., AKKURT İ., SEYFİKLİ Z.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.13, sa.11, ss.5735-5739, 2012 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

17. Chemotherapy-Induced Spontaneous Orgasms in a Patient with Breast Cancer

KILIÇKAP S., Kesikli S. A., ERDİŞ E., YÜCEL B.
ANNALS OF PHARMACOTHERAPY , cilt.46, sa.1, ss.144-145, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

18. Serum Levels of Alpha-Tocopherol, Vitamin C, Beta-Carotene, and Retinol in Malignant Pleural Mesothelioma

Emri S., KILIÇKAP S., KADILAR C., HALİL M. G., Akay H., Besler T.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.13, sa.7, ss.3025-3029, 2012 (SCI-Expanded) Creative Commons License identifier identifier identifier

19. FREQUENCY OF CANCER TYPES IN PATIENTS AGED 65 AND OLDER: RESULTS FROM CANCER REGISTRY DATABASE OF HACETTEPE UNIVERSITY HOSPITALS

Arslan C., KILIÇKAP S., Dede D. S., HAYRAN K. M., ERMAN M., ÇELİK İ., et al.
TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI , cilt.14, sa.3, ss.187-192, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

20. Alpha-Fetoprotein Response After Locoregional Therapy for Hepatocellular Carcinoma

KILIÇKAP S., Arslan C., ŞENEL S., ATASEVEN H.
JOURNAL OF CLINICAL ONCOLOGY , cilt.28, sa.6, 2010 (SCI-Expanded) identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 4

1. Effect of the patient's age on radiotherapy-based adverse effect

Okur Y., Yucel B., Akkas E. A., Eren M. F., Babacan N. A., Kacan T., et al.
48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30, (Özet Bildiri) identifier

2. Smoking habits of relatives of patients (pts) with cancer.

Hayran M., Kilickap S., Elkiran T., Akbulut H., Abali H., Yuce D., et al.
48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

3. Association of higher proliferation of Ki67 with unfavorable prognostic factors and shorter survival in breast cancer

KILIÇKAP S., KAYA Y., YÜCEL B., TUNCER E., ELAGÖZ Ş.
48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

4. Assessment of the life quality in head and neck cancer patients.

Akkas E. A., Yucel B., Kilickap S., Okur Y., Kacan T., Eren M. F., et al.
48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30 Sürdürülebilir Kalkınma identifier
Metrikler

Yayın

24

Yayın (WoS)

24

Yayın (Scopus)

20

Atıf (WoS)

140

H-İndeks (WoS)

6

Atıf (Scopus)

60

H-İndeks (Scopus)

3

Açık Erişim

8
BM Sürdürülebilir Kalkınma Amaçları